問卷

TPIDB > Study Site

Study Site



Chang Gung Medical Foundation Chang Gung Memorial Hospital, Keelung

  • 1,089

    Total Beds

  • 275

    Total Doctors

  • shengyuan@cgmh.org.tw
  • Lin, Sheng-yuan
  • 02-24329292 #2082
  • 204Keelung CityAn LeNo. 222, Maijin Rd., Anle Dist., Keelung City 204015, Taiwan

Site Introduction

The Keelung Clinical Trial Center is located in the Lover Lake District of Keelung Chang Gung Memorial Hospital. We provide a comprehensive clinical trial execution environment, including trial document storage space、 trial specimen processing and storage space, and trial data monitoring space, etc. To assist in-hospital clinical trial studies in application and various services and coordination during the execution phase ensure the quality of clinical trial execution and the safety of participants.
On the other hand, we are also actively handling various types of education and training for researchers, providing a platform for moderators and research team members to communicate on clinical research, and strengthening the effectiveness of clinical trial implementation.

Clinical Trials List

See All174Cases

2016

Total 174

  • I 4

  • I/II 4

  • II 36

  • II/III 9

  • III 101

  • IV 6

  • Others 14

Number of Studies by Scale

37件

Taiwan Multiple Center

Taiwan Single Center

3Cases

Taiwan Multiple Center

37Cases

Multi-Regional Multi-Center

131Cases

Principal Investigators - Rank by Total Number of Studies

No 1
ChienRong-Nan

Total Studies20

  • Phase I

    2

  • Phase I/II

    2

  • Phase II

    5

  • Phase III

    6

  • Phase IV

    1

  • Others

    4

Phase I

2Cases

Phase I/II

2Cases

Phase II

5Cases

Phase II/III

0Cases

Phase III

6Cases

Phase IV

1Cases

Others

4Cases

No 2

Total Studies20

  • Phase I

    1

  • Phase II

    2

  • Phase II/III

    3

  • Phase III

    14

Phase I

1Cases

Phase I/II

0Cases

Phase II

2Cases

Phase II/III

3Cases

Phase III

14Cases

Phase IV

0Cases

Others

0Cases

No 3
WUI-WEN

Total Studies10

  • Phase II

    4

  • Phase II/III

    2

  • Phase III

    4

Phase I

0Cases

Phase I/II

0Cases

Phase II

4Cases

Phase II/III

2Cases

Phase III

4Cases

Phase IV

0Cases

Others

0Cases

No 4

Total Studies17

  • Phase II

    3

  • Phase III

    13

  • Others

    1

Phase I

0Cases

Phase I/II

0Cases

Phase II

3Cases

Phase II/III

0Cases

Phase III

13Cases

Phase IV

0Cases

Others

1Cases

No 5

Total Studies13

  • Phase III

    11

  • Phase IV

    1

  • Others

    1

Phase I

0Cases

Phase I/II

0Cases

Phase II

0Cases

Phase II/III

0Cases

Phase III

11Cases

Phase IV

1Cases

Others

1Cases

No 6
ChenChingYen

Total Studies4

  • Phase II/III

    1

  • Phase III

    3

Phase I

0Cases

Phase I/II

0Cases

Phase II

0Cases

Phase II/III

1Cases

Phase III

3Cases

Phase IV

0Cases

Others

0Cases

No 7

Total Studies7

  • Phase II

    2

  • Phase III

    4

  • Phase IV

    1

Phase I

0Cases

Phase I/II

0Cases

Phase II

2Cases

Phase II/III

0Cases

Phase III

4Cases

Phase IV

1Cases

Others

0Cases

No 8

Total Studies14

  • Phase I/II

    1

  • Phase II

    4

  • Phase III

    7

  • Phase IV

    2

Phase I

0Cases

Phase I/II

1Cases

Phase II

4Cases

Phase II/III

0Cases

Phase III

7Cases

Phase IV

2Cases

Others

0Cases

No 9
PanHeng-Chih

Total Studies7

  • Phase II

    2

  • Phase III

    5

Phase I

0Cases

Phase I/II

0Cases

Phase II

2Cases

Phase II/III

0Cases

Phase III

5Cases

Phase IV

0Cases

Others

0Cases

No 10

Total Studies4

  • Phase II

    1

  • Others

    3

Phase I

0Cases

Phase I/II

0Cases

Phase II

1Cases

Phase II/III

0Cases

Phase III

0Cases

Phase IV

0Cases

Others

3Cases

Patient Recruitment Ranking